- Home
- RLAY vs PRG Comparison
RLAY vs PRG Comparison
Compare RLAY & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | PRG |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | United States |
| Employees | N/A | 1151 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RLAY | PRG |
|---|---|---|
| Price | $9.59 | $28.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | $16.86 | ★ $47.50 |
| AVG Volume (30 Days) | ★ 2.5M | 494.2K |
| Earning Date | 05-04-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.79% |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ 3.59 |
| Revenue | $15,355,000.00 | ★ $2,409,223,000.00 |
| Revenue This Year | N/A | $24.02 |
| Revenue Next Year | $324.03 | $7.06 |
| P/E Ratio | ★ N/A | $8.09 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $1.78 | $23.50 |
| 52 Week High | $11.49 | $41.14 |
Technical Indicators
Market Signals| Indicator | RLAY | PRG |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 36.62 |
| Support Level | $9.06 | $27.58 |
| Resistance Level | $11.46 | $30.68 |
| Average True Range (ATR) | 0.63 | 1.01 |
| MACD | -0.12 | -0.02 |
| Stochastic Oscillator | 16.18 | 19.92 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.